Articles published by Harrow, Inc.
![](https://mms.businesswire.com/media/20240807453796/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow Announces Second Quarter 2024 Financial Results
August 07, 2024
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20240725144463/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024
July 25, 2024
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20240712085689/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow to Attend 2024 ASRS Annual Meeting
July 12, 2024
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20240709623740/en/2180223/22/Apexus_Logo.jpg)
![](https://mms.businesswire.com/media/20240620854415/en/2164990/5/triesence_product_shot.jpg)
Harrow Provides TRIESENCE® Relaunch Update
June 20, 2024
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20240605338632/en/1533746/5/Harrow_logo_wTag.jpg)
![](https://mms.businesswire.com/media/20240515334076/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow to Present at Two Investor Conferences in May
May 15, 2024
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20240513953027/en/1533746/5/Harrow_logo_wTag.jpg)
![](https://mms.businesswire.com/media/20240513390675/en/1533746/5/Harrow_logo_wTag.jpg)
![](https://mms.businesswire.com/media/20240425737701/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow Will Release First Quarter 2024 Financial Results After Market Close on May 13, 2024
April 25, 2024
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20240319708486/en/1533746/5/Harrow_logo_wTag.jpg)
![](https://mms.businesswire.com/media/20240305397352/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024
March 05, 2024
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20240215859659/en/2036304/22/Apotex_Logo-002.jpg)
Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products
February 15, 2024
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20240129007677/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow Announces New Appointments to its Board of Directors
January 29, 2024
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20240111803510/en/1533746/5/Harrow_logo_wTag.jpg)
![](https://mms.businesswire.com/media/20240103973471/en/1533746/5/Harrow_logo_wTag.jpg)
![](https://mms.businesswire.com/media/20231129601830/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow Completes Transfer of the TRIESENCE® New Drug Application
November 29, 2023
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20231120551397/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow to Present at Two Investor Conferences in November
November 20, 2023
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20231113816178/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow Announces Third Quarter 2023 Financial Results
November 13, 2023
From Harrow, Inc.
Via Business Wire
Tickers
HROW
![](https://mms.businesswire.com/media/20231030960332/en/1533746/5/Harrow_logo_wTag.jpg)
![](https://mms.businesswire.com/media/20231024223365/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.
October 24, 2023
From Harrow, Inc.
Via Business Wire
Tickers
HROW
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.